Signal transduction in ischemic preconditioning:: The role of kinases and mitochondrial KATP channels

被引:89
作者
Baines, CP
Cohen, MV
Downey, JM
机构
[1] Univ S Alabama, Dept Physiol, Coll Med, Mobile, AL 36688 USA
[2] Univ S Alabama, Dept Med, Coll Med, Mobile, AL 36688 USA
关键词
ischemic preconditioning; adenosine; protein kinase C; tyrosine kinase; mitogen-activated protein kinase; K-ATP channels;
D O I
10.1111/j.1540-8167.1999.tb00251.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Signaling in Preconditioning. Ischemic preconditioning is a phenomenon whereby exposure of the myocardium to a brief episode of ischemia and reperfusion markedly reduces tissue necrosis induced by a subsequent prolonged ischemia. Therefore, it is hoped that elucidation of the mechanism of preconditioning will yield therapeutic strategies capable of reducing myocardial infarction. In the rabbit, the brief period of preconditioning ischemia and reperfusion releases adenosine, bradykinin, opioids, and oxygen radicals that summate to induce the translocation and activation of protein kinase C (PKC). PKC appears to be the first element of a complex kinase cascade that is activated during the prolonged ischemia in preconditioned hearts. Current evidence indicates that PKC activates a tyrosine kinase that leads to the activation of p38 mitogen-activated protein (MAP) kinase or JNK, or possibly both. The stimulation of these stress-activated protein kinases ultimately induces the opening of mitochondrial K-ATP channels that may be the final mediator of protection by ischemic preconditioning. (J Cardiovasc Electrophysiol, Vol. 10, pp. 741-754, May 1999).
引用
收藏
页码:741 / 754
页数:14
相关论文
共 111 条
[21]   Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3 - MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo [J].
Deacon, K ;
Blank, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14489-14496
[22]   ADAPTATION TO ISCHEMIA DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - CLINICAL, HEMODYNAMIC, AND METABOLIC FEATURES [J].
DEUTSCH, E ;
BERGER, M ;
KUSSMAUL, WG ;
HIRSHFELD, JW ;
HERRMANN, HC ;
LASKEY, WK .
CIRCULATION, 1990, 82 (06) :2044-2051
[23]  
Downey JM, 1995, Z KARDIOL, V84, P77
[24]   Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli [J].
Foltz, IN ;
Gerl, RE ;
Wieler, JS ;
Luckach, M ;
Salmon, RA ;
Schrader, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :9344-9351
[25]   INTERLEUKIN-1 ACTIVATES A NOVEL PROTEIN-KINASE CASCADE THAT RESULTS IN THE PHOSPHORYLATION OF HSP27 [J].
FRESHNEY, NW ;
RAWLINSON, L ;
GUESDON, F ;
JONES, E ;
COWLEY, S ;
HSUAN, J ;
SAKLATVALA, J .
CELL, 1994, 78 (06) :1039-1049
[26]  
Garlid KD, 1997, CIRC RES, V81, P1072
[27]   Cation transport in mitochondria - The potassium cycle [J].
Garlid, KD .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1996, 1275 (1-2) :123-126
[28]   ROLE OF BRADYKININ IN PROTECTION OF ISCHEMIC PRECONDITIONING IN RABBIT HEARTS [J].
GOTO, M ;
LIU, YG ;
YANG, XM ;
ARDELL, JL ;
COHEN, MV ;
DOWNEY, JM .
CIRCULATION RESEARCH, 1995, 77 (03) :611-621
[29]   Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection [J].
Goto, M ;
Cohen, MV ;
VanWylen, DGL ;
Downey, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (03) :447-454
[30]   A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death [J].
Gray, MO ;
Karliner, JS ;
Mochly-Rosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30945-30951